Dupont Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-44,091
| Closed | -$158K | – | 1708 |
|
|
2022
Q1 | $158K | Sell |
44,091
-3,900
| -8% | -$14K | 0.01% | 1149 |
|
|
2021
Q4 | $188K | Buy |
47,991
+7,922
| +20% | +$31K | 0.01% | 1141 |
|
|
2021
Q3 | $264K | Sell |
40,069
-5,664
| -12% | -$37.3K | 0.01% | 1118 |
|
|
2021
Q2 | $282K | Buy |
+45,733
| New | +$282K | 0.01% | 1217 |
|
|
2020
Q3 | – | Sell |
-76,246
| Closed | -$306K | – | 1373 |
|
|
2020
Q2 | $306K | Sell |
76,246
-122,961
| -62% | -$493K | 0.01% | 962 |
|
|
2020
Q1 | $506K | Hold |
199,207
| – | – | 0.01% | 657 |
|
|
2019
Q4 | $693K | Buy |
199,207
+138,527
| +228% | +$482K | 0.02% | 694 |
|
|
2019
Q3 | $281K | Buy |
60,680
+14,690
| +32% | +$68K | 0.01% | 1027 |
|
|
2019
Q2 | $567K | Buy |
+45,990
| New | +$567K | 0.01% | 722 |
|